BRAIN Biotech AG financial highlights

in € million 2019/20 2018/19 2017/18
Consolidated income statement data:
Revenue 38.2 38.6 27.1
Total operating performance 39.2 41.2 30.5
EBITDA –3.9 –2.5 –6.6
Adjusted EBITDA –2.0 –2.1 –5.3
Net loss for the reporting period –9.0 –10.5 –8.1
Consolidated balance sheet data:
Total equity 26.1 17.1 28.4
Equity ratio (in %) 36.2% 25.8% 38.2%
Total assets 72.2 66.1 74.5
Consolidated cash flow data:
Cash flows from operating activities –4.8 –3.4 ‒5.4
Cash flows from investing activities –4.5 –6.7 –12.6
Cash flows from financing activities 13.1 –0.3 4.7

Share this page